| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/09/2005 | US20050123513 Use of a reovirus for the manufacture of a medicament for treating a Ras-mediated neoplasm; administering reovirus to a Ras-mediated neoplasm without the side effects associated with other forms of cancer therapy; anticancer |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | US20050123511 vector comprising heterologous nucleic acid molecules that code antigenic polypeptides |
| 06/09/2005 | US20050123508 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 06/09/2005 | DE10352366A1 Vector system that includes transcribable gene and pH-sensitive reporter gene, useful for identifying enzymes that catalyze pH-dependent reactions, also derived expression and substance libraries |
| 06/09/2005 | DE102004047056A1 Kartoffeln mit erhöhter Ausbeute an Stärke pro Pflanzenkörper und Verfahren zur Herstellung derselben Potatoes with increased yield of starch per plant body and method of manufacturing the same |
| 06/09/2005 | DE10154317B4 Verfahren zum Nachweis von Cytosin-Methylierungen in immobilisierten DNA Proben A method for the detection of cytosine methylations in DNA samples immobilized |
| 06/09/2005 | DE10144664B4 Vacciniavirus MVA-E3L-Knock-Out-Mutanten und Verwendung hiervon Vaccinia virus MVA-E3L knock-out mutants and use thereof |
| 06/09/2005 | DE10047286B4 Isomalt produzierende transgene Pflanze Isomalt producing transgenic plant |
| 06/09/2005 | CA2590257A1 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses |
| 06/09/2005 | CA2552553A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 06/09/2005 | CA2548202A1 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 06/09/2005 | CA2547459A1 Modulators of nik-siva complex formation for treating immune disorders |
| 06/09/2005 | CA2547326A1 Novel muscle growth regulator |
| 06/09/2005 | CA2547320A1 Fatty acid elongase (fae) genes and their utility in increasing erucic acid and other very long-chain fatty acid proportions in seed oil |
| 06/09/2005 | CA2547165A1 Mutated anti-cd22 antibodies and immunoconjugates |
| 06/09/2005 | CA2547126A1 Substance binding human igg fc receptor iib (fcyriib) |
| 06/09/2005 | CA2547034A1 Anticarcinoma antibodies and uses thereof |
| 06/09/2005 | CA2546775A1 A system for plasmid maintenance comprising a cell growth inhibiting chromosomal gene and a plasmid encoding antisense sequence |
| 06/09/2005 | CA2546763A1 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 06/09/2005 | CA2546659A1 Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates |
| 06/09/2005 | CA2546619A1 Il-23 and its receptor; related reagents and methods |
| 06/09/2005 | CA2546616A1 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification |
| 06/09/2005 | CA2546614A1 Dna participating in hydroxylation of macrolide compound |
| 06/09/2005 | CA2546451A1 Serine proteases, nucleic acids encoding serine enzymes and vectors and host cells incorporating same |
| 06/09/2005 | CA2546428A1 Compositions and methods for the diagnosis and treatment of tumor |
| 06/09/2005 | CA2546326A1 Novel agents for the prevention of leishmaniosis |
| 06/09/2005 | CA2546287A1 Reduction of dermal scarring |
| 06/09/2005 | CA2546222A1 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
| 06/09/2005 | CA2546178A1 New use of adenovirus and nucleic acids coding therefor |
| 06/09/2005 | CA2545815A1 Adenoviral vectored tnf-a and chemoradiation to treat cancer |
| 06/09/2005 | CA2545610A1 Auxotrophic pseudomonas fluorescens bacteria for recombinant protein expression |
| 06/09/2005 | CA2545553A1 Methods for producing olfactory gpcrs |
| 06/09/2005 | CA2543566A1 B-cell-targeted toxin for immuno response reduction |
| 06/09/2005 | CA2541970A1 Gene silencing by using micro-rna molecules |
| 06/08/2005 | EP1538222A1 Oligonucleotides for the detection of salmonella |
| 06/08/2005 | EP1538221A1 Oligonucleotides containing molecular rods |
| 06/08/2005 | EP1538211A1 Novel glycerol kinase, gene thereof and process for producing the glycerol kinase by using the gene |
| 06/08/2005 | EP1538210A2 Dna-based vaccination of fish by immersion |
| 06/08/2005 | EP1538209A2 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 06/08/2005 | EP1538208A2 Mutants of streptococcal toxin A and methods of use |
| 06/08/2005 | EP1538207A1 Human antihuman mcp-1 antibody and antibody fragment thereof |
| 06/08/2005 | EP1538206A2 Method for the complete chemical synthesis and assembly of genes and genomes |
| 06/08/2005 | EP1538204A2 Mutated subtilisin genes |
| 06/08/2005 | EP1538202A2 Production of human alpha-galactosidase A |
| 06/08/2005 | EP1538162A2 Compositions for altering mucus secretion |
| 06/08/2005 | EP1538157A2 Isolation and use of SH3 binding peptides |
| 06/08/2005 | EP1538155A2 Amylase variants |
| 06/08/2005 | EP1537911A2 A medium for chromatographic separations |
| 06/08/2005 | EP1537877A2 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 06/08/2005 | EP1537488A2 Systems and methods for predicting oligonucleotide melting temperatures (tms) |
| 06/08/2005 | EP1537417A2 Method of diagnosing colon and gastric cancers |
| 06/08/2005 | EP1537415A2 Methods of diagnosing cervical cancer |
| 06/08/2005 | EP1537245A2 Dna chips used for bioprocess control |
| 06/08/2005 | EP1537243A1 Method of diagnosing ovarian endometriosis |
| 06/08/2005 | EP1537242A1 Method for preparation of cdna tags for identifying expressed genes and method for analysis of gene expression |
| 06/08/2005 | EP1537238A1 Method and test kit for quantitative determination of polynucleotides in a mixture |
| 06/08/2005 | EP1537237A2 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 06/08/2005 | EP1537235A2 Diagnostic assays for parvovirus b19 |
| 06/08/2005 | EP1537233A2 Gtp cyclohydrolase ii as a target for fungicides |
| 06/08/2005 | EP1537228A2 Modulators of angiogenesis |
| 06/08/2005 | EP1537227A2 Method for efficient rna interference in mammalian cells |
| 06/08/2005 | EP1537225A2 Method for zymotic production of fine chemicals (mety) containing sulphur |
| 06/08/2005 | EP1537224A2 Method for zymotic production of fine chemicals (meta) containing sulphur |
| 06/08/2005 | EP1537223A2 Method for the production by fermentation of sulphur-containing fine chemicals (metf) |
| 06/08/2005 | EP1537218A2 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 06/08/2005 | EP1537217A1 Plants transformed with cdc27a, having changed development |
| 06/08/2005 | EP1537216A2 Transformed plants with enhanced prenylquinone biosynthesis |
| 06/08/2005 | EP1537215A2 Zinc-regulated prokaryotic expression cassettes |
| 06/08/2005 | EP1537214A2 Regulated bacterial lysis for gene vaccine vector delivery and antigen release |
| 06/08/2005 | EP1537213A2 Protein kinases |
| 06/08/2005 | EP1537212A2 Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases |
| 06/08/2005 | EP1537211A2 Isolated cytokine receptor licr-2 |
| 06/08/2005 | EP1537210A1 Decoy-oligonucleotide-inhbition of cd40-expression |
| 06/08/2005 | EP1537209A2 Functional correction of the sp -786 /sp c/t variance of the human i enos /i gene |
| 06/08/2005 | EP1537208A1 Non-sequence complementary antiviral oligonucleotides |
| 06/08/2005 | EP1537207A2 Recombinant colstridium neurotoxin fragments |
| 06/08/2005 | EP1537206A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/08/2005 | EP1537205A2 Viral deconstruction through capsid assembly in vitro |
| 06/08/2005 | EP1537202A2 Methods and reagents for surface functionalization |
| 06/08/2005 | EP1537145A1 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 06/08/2005 | EP1537142A1 Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same |
| 06/08/2005 | EP1537138A2 Receptors and membrane-associated proteins |
| 06/08/2005 | EP1537137A2 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 06/08/2005 | EP1537136A2 Promoters for regulation of gene expression in plant roots |
| 06/08/2005 | EP1536840A2 Formulation for inwardly transferring nucleic acids into eucaryotic cells |
| 06/08/2005 | EP1536828A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 06/08/2005 | EP1536818A2 Fibrinogen binding moieties |
| 06/08/2005 | EP1536812A2 Methods for modulating activity of the fxr nuclear receptor |
| 06/08/2005 | EP1536807A2 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 06/08/2005 | EP1536689A2 Gene therapy for critical limb ischemia with wild type or mutant enos |
| 06/08/2005 | EP1536688A2 Mammalian megakaryocyte progenitor cell |
| 06/08/2005 | EP1497465A4 Constant length signatures for parallel sequencing of polynucleotides |
| 06/08/2005 | EP1417311A4 Maize basal layer antimicrobial protein polynucleotides and methods of use |
| 06/08/2005 | EP1278890A4 A method of detecting neoplastic or non-neoplastic cells |
| 06/08/2005 | EP1169441B1 Pharmaceutical compositions for the treatment of heart failure |
| 06/08/2005 | EP1112367B8 Agents and methods for modifying the glutamine metabolism in plants, especially in sugar beet |
| 06/08/2005 | EP1102775B1 Novel phospholipids with unsaturated alkyl and acyl chains |
| 06/08/2005 | EP1097174B1 Lupus anticoagulant antibody to f1 region of prothrombin |
| 06/08/2005 | EP1092017A4 Novel gaba-b receptor |